References

Paraneoplastic signs and symptoms of renal cell carcinoma: implications for prognosis

10.1097/01.ju.0000092764.81308.6a · 2003 · External reference

Kidney cancer: identification of novel targets for therapy

10.1038/sj.ki.5000065 · 2006 · External reference

The role of C-reactive protein as a prognostic indicator in advanced cancer

10.1007/s11912-002-0023-1 · 2002 · External reference

C-reactive protein: a biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherapy

10.1097/01.ju.0000146713.50673.e5 · 2005 · External reference

Prognostic value of thrombocytosis in renal cell carcinoma

10.1016/s0022-5347(05)00526-4 · 2006 · External reference

Expression of the interleukin 6 receptor in primary renal cell carcinoma

10.1136/jcp.50.10.835 · 1997 · External reference

Expression of C-reactive protein by renal cell carcinomas and unaffected surrounding renal tissue

10.1111/j.1523-1755.2005.00666.x · 2005 · External reference

Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma

10.1002/(sici)1097-0215(19970729)72:3<424::aid-ijc9>3.0.co;2-r · 1997 · External reference

FDG-PET imaging in patients with paraneoplastic syndromes and suspected small cell lung cancer

10.1097/00005382-200104000-00004 · 2001 · External reference

FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes

10.1093/brain/awh247 · 2004 · External reference

Paraneoplastic syndromes: detection of malignant tumors using [(18)F]FDG-PET

2003 · External reference

Efficiency of [(18)F]FDG PET in characterising renal cancer and detecting distant metastases: a comparison with CT

10.1007/s00259-003-1211-4 · 2003 · External reference

2-Deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography in characterization of solid renal masses

10.1007/s11307-005-0026-z · 2005 · External reference